Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,348,000 | 9,595,000 | 5,901,000 | 27,000 | 9,644 |
| Marketable Securities | 26,000 | 300,000 | 2,075,000 | 626,000 | 1,131 |
| Receivables | 3,735,000 | 4,803,000 | 4,298,000 | 3,817,000 | 3,373,104 |
| Inventories | 1,124,000 | 1,150,000 | 1,091,000 | 872,000 | 836,270 |
| Income taxes - deferred | 896,000 | 766,000 | 669,000 | 1,469,000 | 1,636,811 |
| Other current assets | 0 | 0 | 0 | 0 | 1,872,490 |
| TOTAL | $16,081,000 | $17,848,000 | $15,354,000 | $7,354,000 | $8,218,493 |
| Non-Current Assets | |||||
| PPE Net | 2,485,000 | 2,298,000 | 2,247,000 | 2,144,000 | 2,357,563 |
| Investments And Advances | 92,000 | 118,000 | 119,000 | 229,000 | 137,360 |
| Intangibles | 7,375,000 | 8,167,000 | 8,453,000 | 9,010,000 | 9,888,360 |
| Other Non-Current Assets | 1,480,000 | 767,000 | 835,000 | 784,000 | 532,927 |
| TOTAL | $11,432,000 | $11,350,000 | $11,654,000 | $12,167,000 | $12,916,210 |
| Total Assets | $27,513,000 | $29,198,000 | $27,008,000 | $19,521,000 | $21,134,710 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,439,000 | 431,000 | 1,042,000 | 16,000 | N/A |
| Accounts payable and accrued liabilities | 6,954,000 | 6,448,000 | 5,734,000 | 5,881,000 | 356,784 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 1,406,516 |
| Other current liabilities | N/A | N/A | N/A | N/A | 441,842 |
| TOTAL | $11,393,000 | $6,879,000 | $6,776,000 | $5,897,000 | $3,761,248 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,538,000 | 14,292,000 | 14,630,000 | 32,000 | N/A |
| Other Non-Current Liabilities | 3,681,000 | 3,535,000 | 2,239,000 | 1,660,000 | 1,670,458 |
| TOTAL | $14,378,000 | $17,827,000 | $16,869,000 | $1,692,000 | $1,670,458 |
| Total Liabilities | $25,771,000 | $24,706,000 | $23,645,000 | $7,589,000 | $5,431,706 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,593,887 | 1,588,519 | 1,577,334 | N/A | N/A |
| Common Shares | 16,000 | 16,000 | 0 | N/A | N/A |
| Retained earnings | 535,000 | 1,567,000 | 0 | N/A | N/A |
| Other shareholders' equity | -2,031,000 | -442,000 | 3,363,000 | 11,932,000 | 15,703,000 |
| TOTAL | $1,742,000 | $4,492,000 | $3,363,000 | $11,932,000 | $15,703,000 |
| Total Liabilities And Equity | $27,513,000 | $29,198,000 | $27,008,000 | $19,521,000 | $21,134,706 |